These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36227333)

  • 1. Clinical pharmacokinetics of terbutaline in humans: a systematic review.
    Sultan K; Zamir A; Ashraf W; Imran I; Saeed H; Rehman AU; Majeed A; Rasool MF
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):213-227. PubMed ID: 36227333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.
    Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F
    Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline-terbutaline, a steady state study on possible pharmacokinetic interactions with special reference to chronopharmacokinetic aspects.
    Jonkman JH; Borgström L; van der Boon WJ; de Noord OE
    Br J Clin Pharmacol; 1988 Sep; 26(3):285-93. PubMed ID: 3179168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
    Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacokinetics of Metoprolol: A Systematic Review.
    Zamir A; Hussain I; Ur Rehman A; Ashraf W; Imran I; Saeed H; Majeed A; Alqahtani F; Rasool MF
    Clin Pharmacokinet; 2022 Aug; 61(8):1095-1114. PubMed ID: 35764772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic properties and tolerability of single-dose terbutaline in patients with severe asthma treated in the pediatric intensive care unit.
    Lebovitz DJ; Smith PG; O'Riordan M; Reed MD
    Curr Ther Res Clin Exp; 2004 Jan; 65(1):98-109. PubMed ID: 24936108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.
    Hochhaus G; Möllmann H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):342-62. PubMed ID: 1358833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics.
    Svedmyr K
    Allergy; 1982 Feb; 37(2):119-27. PubMed ID: 6127964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does theophylline potentiate inhaled beta 2-agonists?
    Svedmyr K; Svedmyr N
    Allergy; 1982 Feb; 37(2):101-10. PubMed ID: 6127963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral terbutaline alone and in combination with theophylline: dose, plasma concentration, and effect in long-term treatment of bronchial asthma.
    Stålenheim G; Lindström B; Lönnerholm G
    Eur Respir J; 1989 Oct; 2(9):861-7. PubMed ID: 2806513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of terbutaline to optimal theophylline therapy. Double blind crossover study in asthmatic patients.
    Vandewalker ML; Kray KT; Weber RW; Nelson HS
    Chest; 1986 Aug; 90(2):198-203. PubMed ID: 3525022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased theophylline clearance in asthmatic patients due to terbutaline.
    Garty M; Paul-Keslin L; Ilfeld DN; Mazar A; Spitzer S; Rosenfeld JB
    Eur J Clin Pharmacol; 1989; 36(1):25-8. PubMed ID: 2917584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of short-term subcutaneous terbutaline on theophylline disposition.
    Snidow J; Stephens M; Self T; Stewart C; Bobo L; Pieper JA
    Eur J Clin Pharmacol; 1987; 32(2):191-3. PubMed ID: 3582484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
    van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):569-73. PubMed ID: 3023243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of bambuterol in healthy subjects.
    Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
    Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists.
    Rosenburg J
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S1-21. PubMed ID: 12214578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of terbutaline in chronic kidney disease.
    Bastiansen A; Eggert S; Pedersen E
    Eur J Clin Pharmacol; 2013 Nov; 69(11):1951-4. PubMed ID: 23900693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men.
    Dyreborg A; Krogh N; Backer V; Rzeppa S; Hemmersbach P; Hostrup M
    Front Pharmacol; 2016; 7():150. PubMed ID: 27375484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis.
    van der Vet AP; Kreukniet J; van Drost RH; Maes RA; Fokkens JK; Hamelink MJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):558-64. PubMed ID: 2828249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels.
    Billing B; Dahlqvist R; Garle M; Hörnblad Y; Ripe E
    Eur J Respir Dis; 1982 Sep; 63(5):399-409. PubMed ID: 7140872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.